Pages that link to "Q36070497"
Jump to navigation
Jump to search
The following pages link to Efficacy of Olanzapine Combined Therapy for Patients Receiving Highly Emetogenic Chemotherapy Resistant to Standard Antiemetic Therapy (Q36070497):
Displaying 7 items.
- Effect of Persian Medicine Remedy on Chemotherapy Induced Nausea and Vomiting in Breast Cancer: A Double Blind, Randomized, Crossover Clinical Trial (Q37641334) (← links)
- Contributions of the Japanese Gynecologic Oncology Group (JGOG) in Improving the Quality of Life in Women With Gynecological Malignancies (Q38743786) (← links)
- Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan (Q39137612) (← links)
- Effectiveness of olanzapine in patients who fail therapy with aprepitant while receiving highly emetogenic chemotherapy. (Q47296270) (← links)
- Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial (Q50441498) (← links)
- Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Comparative Study From Sudan (Q91630545) (← links)
- The use of olanzapine as an antiemetic in palliative medicine: a systematic review of the literature (Q93160016) (← links)